Browse Drug Recalls
2,101 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,101 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,101 FDA drug recalls in NJ.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Nov 29, 2017 | Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Z... | Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets... | Class II | Prinston Pharmaceutical Inc |
| Nov 20, 2017 | Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count... | Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets | Class II | Zydus Pharmaceuticals USA Inc |
| Nov 20, 2017 | Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: G... | CGMP Deviations: Market complaints related to "gritty texture". | Class II | Glenmark Pharmaceuticals Inc., USA |
| Nov 13, 2017 | Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by:... | Failed Impurities/Degradation Specifications | Class III | Elite Laboratories Inc. |
| Nov 11, 2017 | Fluconazole Injection, USP, 2 mg/mL, a) 50 mL (NDC 336000-261-10) and b) 100 ... | Superpotent | Class III | Renaissance Lakewood, LLC |
| Nov 10, 2017 | Bayer Chewable Low Dose Aspirin 81 mg Orange Flavored 36 tablets, Made in Spa... | Failed Stability Specifications | Class III | Bayer HealthCare Pharmaceuticals, Inc. |
| Nov 6, 2017 | Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Via... | Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone... | Class III | West-Ward Pharmaceuticals Corp. |
| Nov 6, 2017 | Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, ... | Superpotent | Class III | Claris Lifesciences Inc |
| Nov 6, 2017 | Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-... | Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone... | Class III | West-Ward Pharmaceuticals Corp. |
| Oct 30, 2017 | Doan's Pain Relieving Cream with 4% Lidocaine Plus Menthol, (lidocaine 4%, me... | Labeling: Incorrect or Missing Lot and/or Exp Date; lot number on the secondary packaging doesnt... | Class III | Dr. Reddy's Laboratories, Inc. |
| Oct 13, 2017 | Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: T... | Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the i... | Class III | Sanofi-Aventis U.S. LLC |
| Oct 3, 2017 | Famotidine tablets, 10 mg, packaged in 30-count bottle, OTC, labeled as a) CV... | Failed impurities/degradation specifications: Famotodine has an out of specification result for a... | Class III | Dr. Reddy's Laboratories, Inc. |
| Oct 2, 2017 | Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured ... | Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was o... | Class II | Unichem Pharmaceuticals Usa Inc |
| Sep 28, 2017 | Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured b... | Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablet... | Class II | Leading Pharma, LLC |
| Sep 25, 2017 | Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78... | Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap ... | Class III | Sandoz Inc |
| Sep 15, 2017 | ChloraPrep OneStep (Clear) (2% w/v chlorhexidine gluconate (CHG) and 70% v/v ... | Labeling; Label Mixup; the immediate package is labeled incorrectly as Chloroprep Onestep (Clear)... | Class II | Becton Dickinson & Company |
| Aug 23, 2017 | Choice Antibacterial Hand Soap, (ethyl alcohol 61%) 800 ml/ 27 fl oz, Univer... | GMP Deviations; potential bacterial contamination may have been introduced to products through a ... | Class II | Inopak Ltd |
| Aug 23, 2017 | Mild Healthcare Antibacterial Hand Soap, 6% P.C.M.X., 1000 mL and 2000 mL Dis... | GMP Deviations; potential bacterial contamination may have been introduced to products through a ... | Class II | Inopak Ltd |
| Aug 23, 2017 | Option Systems Antibacterial Foaming Hand Wash, 0.3% P.C.M.X., 8 fl oz and 18... | GMP Deviations; potential bacterial contamination may have been introduced to products through a ... | Class II | Inopak Ltd |
| Aug 22, 2017 | Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufacture... | Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specificatio... | Class III | Wockhardt Usa Inc. |
| Aug 18, 2017 | Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cad... | Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets | Class II | Zydus Pharmaceuticals USA Inc |
| Jul 20, 2017 | Entecavir Tablets 0.5 mg, 30 tablets per container, Rx Only, Manufactured for... | Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/... | Class II | Hetero USA Inc |
| Jul 11, 2017 | Pravastatin Sodium Tablets, USP, 10 mg, packaged in a) 90-count bottles (NDC ... | Failed Impurities/Degradation Specifications: high out of specification results for related impur... | Class III | Dr. Reddy's Laboratories, Inc. |
| Jun 28, 2017 | Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only,... | Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being ... | Class III | Valeant Pharmaceuticals North America LLC |
| Jun 28, 2017 | parodontax WHITENING (Stannous fluoride) Daily Fluoride Anticavity and Antigi... | Presence of Foreign Substance: possibility of the presence of metal in the product. | Class II | GSK Consumer Healthcare |
| Jun 16, 2017 | Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 15, 2017 | Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. ... | Defective container: Oral solution leaking from container. | Class II | Tris Pharma Inc. |
| Jun 12, 2017 | Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor C... | Superpotent Drug: high out-of-specification result for magnesium. | Class III | Sanofi-Aventis U.S. LLC |
| Jun 5, 2017 | EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squ... | Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eli... | Class I | Bristol-myers Squibb Company |
| Jun 2, 2017 | G & W Clobetasol Propionate Ointment 0.05%, packaged in a) 15 g tube (NDC 071... | Failed impurities/degradation specifications: This product is being recalled due to out of specif... | Class III | G & W Laboratories, Inc. |
| Jun 1, 2017 | Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a... | Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsu... | Class II | Lucid Pharma LLC |
| May 22, 2017 | Zenatane (isotretinoin) Capsules, USP, 40 mg, 30-count (3 x 10 Prescription P... | Failed Dissolution Specifications: out of specification results observed for low dissolution. | Class II | Dr. Reddy's Laboratories, Inc. |
| May 22, 2017 | Zenatane (isotretinoin) Capsules, USP, 30 mg, 30-count (3 x 10 Prescription P... | Failed Dissolution Specifications: out of specification results observed for low dissolution. | Class II | Dr. Reddy's Laboratories, Inc. |
| May 22, 2017 | Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription P... | Failed Dissolution Specifications: out of specification results observed for low dissolution. | Class II | Dr. Reddy's Laboratories, Inc. |
| May 22, 2017 | Zenatane (isotretinoin) Capsules, USP, 20 mg, 30-count (3 x 10 Prescription P... | Failed Dissolution Specifications: out of specification results observed for low dissolution. | Class II | Dr. Reddy's Laboratories, Inc. |
| May 18, 2017 | Saphris 10 mg (asenapine) sublingual tablets, 6x10 count blister packs, Rx on... | Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually ... | Class II | Forest Laboratories, LLC |
| May 11, 2017 | Oxygen Refrigerated Liquid USP UN 1073, Rx only, At Home Medical 200 American... | GMP Deviations: The firm does not include an SOP for testing for out of specifications. | Class II | AtHome Medical, Inc. |
| May 10, 2017 | Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a.) 100-count bottle ... | Failed Dissolution Specifications | Class II | Zydus Pharmaceuticals USA Inc |
| May 10, 2017 | Divalproex Sodium Delayed Release Tablets, USP, 125 mg, 100-count bottle Rx ... | Failed Dissolution Specifications | Class II | Zydus Pharmaceuticals USA Inc |
| May 10, 2017 | Divalproex Sodium Delayed Release Tablets, USP, 250 mg 100-count bottle (NDC ... | Failed Dissolution Specifications | Class II | Zydus Pharmaceuticals USA Inc |
| May 9, 2017 | Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Str... | Failed Stability Specifications: Out of Specification results obtained for preservative Methylpar... | Class III | Strides Pharma INC |
| May 5, 2017 | AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactu... | PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled w... | Class III | Ascend Laboratories LLC |
| Apr 27, 2017 | Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: ... | Presence of Foreign Substance: human hair melded into tablet. | Class III | Hetero USA Inc |
| Apr 26, 2017 | Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 coun... | Subpotent Drug; Clavulanic Acid | Class III | Sandoz Inc |
| Apr 20, 2017 | Phenobarbital Tablets USP, 100 mg, a) 100 count bottles (NDC 0463-6152-01), b... | Labeling: Label Mixup; potentially mislabeled | Class II | C. O. Truxton |
| Apr 20, 2017 | Phenobarbital Tablets USP, 60 mg, 1000 count bottles, Rx Only, Manufactured b... | Labeling: Label Mixup; potentially mislabeled | Class II | C. O. Truxton |
| Apr 20, 2017 | Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactur... | Labeling: Label Mixup; potentially mislabeled | Class II | C. O. Truxton |
| Apr 20, 2017 | Phenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured b... | Labeling: Label Mixup; potentially mislabeled | Class II | C. O. Truxton |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.